Maxim Bastrakov

Dr. Maxim Bastrakov

N.D. Zelinsky Institute of Organic Chemistry, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Maxim BastrakovMaxim Bastrakov
Maxim Bastrakov
Alexey StarosotnikovAlexey Starosotnikov
Alexey Starosotnikov
Aromatic nitro compounds play a unique role in the synthesis of drugs and pharmaceutically oriented molecules. This field of organic chemistry continues to be in demand and relevant. A significant number of papers are published annually on new general methods for the synthesis of nitrodrugs and related biomolecules. This review is an analysis of the literature on methods for the synthesis of both new and already-known aromatic and heteroaromatic nitrodrugs covering the period from 2010 to the present.

1 May 2015 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
Maxim BastrakovMaxim Bastrakov
Maxim Bastrakov
ASAlexey M. Starosotnikov
Alexey M. Starosotnikov
VKVadim V. Kachala
Vadim V. Kachala
IDIgor L. Dalinger
Igor L. Dalinger
SSSvyatoslav A. Shevelev
Svyatoslav A. Shevelev

Verified
Journal Article
Open access
PDF file
Alexey StarosotnikovAlexey Starosotnikov
Alexey Starosotnikov
Maxim BastrakovMaxim Bastrakov
Maxim Bastrakov
Human immunodeficiency virus (HIV) causes one of the most dangerous diseases—acquired immunodeficiency syndrome (AIDS). An estimated about 40 million people are currently living with HIV worldwide, most of whom are already on antiretroviral therapy. This makes the development of effective drugs to combat this virus very relevant. Currently, one of the dynamically developing areas of organic and medicinal chemistry is the synthesis and identification of new compounds capable of inhibiting HIV-1 integrase—one of the HIV enzymes. A significant number of studies on this topic are published annually. Many compounds inhibiting integrase incorporate pyridine core. Therefore, this review is an analysis of the literature on the methods for the synthesis of pyridine-containing HIV-1 integrase inhibitors since 2003 to the present.

14 September 2012 in Synlett
Verified
Journal Article
Closed access
PDF file
Alexey StarosotnikovAlexey Starosotnikov
Alexey Starosotnikov
Maxim BastrakovMaxim Bastrakov
Maxim Bastrakov
VKVadim V. Kachala
Vadim V. Kachala
PBPavel A. Belyakov
Pavel A. Belyakov
IFIvan Fedyanin
Ivan Fedyanin
SSSvyatoslav A. Shevelev
Svyatoslav A. Shevelev
A new one-step method for the synthesis of nitroiso­indoles was developed on the basis of 1,3-dipolar cycloadditions of unstabilized N-alkyl azomethine ylides with di- and trinitrobenzenes.

1 November 2017 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
Alexey StarosotnikovAlexey Starosotnikov
Alexey Starosotnikov
Maxim BastrakovMaxim Bastrakov
Maxim Bastrakov

1 April 2013 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
Maxim BastrakovMaxim Bastrakov
Maxim Bastrakov
ALA. I. Leonov
A. I. Leonov
ASA. M. Starosotnikov
A. M. Starosotnikov
IFIvan Fedyanin
Ivan Fedyanin
SSS. A. Shevelev
S. A. Shevelev